Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K152044
    Manufacturer
    Date Cleared
    2015-08-14

    (22 days)

    Product Code
    Regulation Number
    870.1340
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Flexor Radial Hydrophilic Introducer Access Set

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Flexor® Radial Hydrophilic Introducer Access Set is intended to introduce diagnostic and interventional devices in radial artery access procedures.

    Device Description

    The Flexor® Radial Hydrophilic Introducer Access Set is an introducer set, supplied with an introducer sheath, dilator, wire guide and access needle. The introducers are available in whole French sizes from 4.0 through 7.0 French and in lengths of 7, 13 and 23 centimeters. The sets are compatible with the supplied 0.018" wire guide. The sets are supplied sterile and intended for one-time use.

    AI/ML Overview

    This document describes a 510(k) premarket notification for the "Flexor® Radial Hydrophilic Introducer Access Set" and its substantial equivalence to a predicate device. However, it does not contain a detailed study with specific acceptance criteria and performance data in the format requested.

    The document states that the Flexor® Radial Hydrophilic Introducer Access Set met applicable design and performance requirements and that predetermined acceptance criteria were met for acute performance, check-flo valve leakage, and biocompatibility. However, it does not provide the specific numerical acceptance criteria or the reported device performance metrics.

    Therefore, I cannot fulfill the request for a table of acceptance criteria and reported device performance, nor can I provide information about sample sizes for test sets, data provenance, number of experts, adjudication methods, MRMC studies, standalone performance, types of ground truth, training set sample size, or how training set ground truth was established, as this information is not present in the provided text.

    The closest information available is:

    • Device: Flexor® Radial Hydrophilic Introducer Access Set
    • Intended Use: To introduce diagnostic and interventional devices in radial artery access procedures.
    • Predicate Device: Flexor® Radial Hydrophilic Introducer Access Set (cleared under 510(k) number K132592).
    • Reason for new submission: Modification of the check-flo valve in response to physician feedback.
    • Tests performed:
      • Acute Performance
      • Check-Flo valve liquid leakage testing
      • Biocompatibility testing (cytotoxicity, sensitization, intracutaneous reactivity, systemic toxicity, pyrogen, hemocompatibility, complement activation, partial thromboplastin time, and thromboresistance in conformance with ISO 10993-1:2009).
    • Outcome of tests: Predetermined acceptance criteria were met for all tests, supporting a determination of substantial equivalence.
    Ask a Question

    Ask a specific question about this device

    K Number
    K132592
    Manufacturer
    Date Cleared
    2014-10-09

    (416 days)

    Product Code
    Regulation Number
    870.1340
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    FLEXOR RADIAL HYDROPHILIC INTRODUCER ACCESS SET

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Flexor® Radial Hydrophilic Introducer Access Set is introduce diagnostic and interventional devices in radial arterv access procedures.

    Device Description

    The Flexor Radial Hydrophilic Introducer Access Set is comprised of an introducer sheath, a dilator, a wire guide, and an access needle.

    AI/ML Overview

    This document describes the Cook, Inc. Flexor® Radial Hydrophilic Introducer Access Set (K132592). It details the testing conducted to demonstrate substantial equivalence to predicate devices, focusing on the quality and performance of the device components.

    1. Table of Acceptance Criteria and Reported Device Performance:

    TestAcceptance CriteriaReported Device Performance
    Dilator and introducer sheath tensile testingPeak load values in accordance with applicable values of BS EN ISO 11070:1999.The predetermined acceptance criteria were met.
    Connecting tube to check-flo tensile testingConnection between the valve body and the connecting tube meets predetermined acceptance criteria under proper clinical use.The predetermined acceptance criteria were met.
    Needle tensile testingPeak load values in accordance with applicable values of BS EN ISO 11070:1999.The predetermined acceptance criteria were met.
    Needle tubing testingTubing resists breakage in accordance with EN ISO 9626:1995.The predetermined acceptance criteria were met.
    Check-Flo valve dislodgement testingCheck-Flo valve not dislodged during insertion and withdrawal when utilized according to intended use.The predetermined acceptance criteria were met.
    Check-Flo valve liquid leakage testingCheck-Flo valve does not experience excessive leakage when utilized according to intended use.The predetermined acceptance criteria were met.
    Dimensional verificationEach component meets dimensions within tolerances of predetermined acceptance criteria.Each component met the dimensions within tolerances of the predetermined acceptance criteria.
    Fluoroscopic visibility evaluationEach component visible under fluoroscopy.The predetermined acceptance criteria were met.
    Design validationAchieves design validation through simulated clinical use where predetermined acceptance criteria were met.The predetermined acceptance criteria were met.
    Insertion and extraction force evaluationInsertion and extraction forces of the dilator through the check-flo valve meet predetermined acceptance criteria, where appropriate.The predetermined acceptance criteria were met, where appropriate.
    Dilator and introducer sheath coating slough-offHydrophilic coating meets requirements for durability.The predetermined acceptance criterion was met.
    Particulate evaluationParticulate counts recorded in continuous flow loop. (Specific acceptance criteria not detailed in the provided text, but the nature of the test implies a limit on particulate generation.)Particulate counts were recorded in continuous flow loop. (Implied that counts were within acceptable limits or characterized sufficiently to demonstrate safety, though specific criteria/results are not stated as "met.")
    Introducer lubricity testingLubricity of the introducer shaft meets predetermined acceptance criterion.The predetermined acceptance criterion was met.
    Coating integrity testingSurface of device, including hydrophilic coating, visually examined at multiple time points (implies no significant degradation or damage).Surface of device, including the hydrophilic coating, was visually examined at multiple time points. (Implied that integrity was maintained, though specific criteria/results are not stated as "met.")
    Wire guide testingMeets predetermined acceptance criteria for resistance to fracture, resistance to damage by flexing, tensile, tip deflection, torque response and torque strength as recommended in BS EN ISO 11070:1999 and "Coronary and Cerebrovascular Guidewire Guidance," January 1995.All predetermined acceptance criteria were met for resistance to fracture, resistance to damage by flexing, tensile, tip deflection, torque response and torque strength as recommended in BS EN ISO 11070:1999 and in "Coronary and Cerebrovascular Guidewire Guidance," January 1995.
    Biocompatibility testingDemonstrated as biocompatible in conformance with applicable sections of ISO 10993-1:2009 for tests including cytotoxicity, sensitization, intracutaneous reactivity, systemic toxicity, pyrogen, hemocompatibility, complement activation, partial thromboplastin time, and thromboresistance.Testing (i.e., cytotoxicity, sensitization, intracutaneous reactivity, systemic toxicity, pyrogen, hemocompatibility, complement activation, partial thromboplastin time, and thromboresistance) demonstrated the device as biocompatible. In conformance with the applicable sections of ISO 10993-1:2009, the predetermined acceptance criteria were met.

    2. Sample size used for the test set and the data provenance:

    The provided document details various performance and laboratory tests. However, it does not specify sample sizes for each test set, nor does it mention data provenance (e.g., country of origin, retrospective or prospective data). These tests appear to be bench and laboratory-based assessments of the device's physical and biological properties.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    This information is not provided in the document. The tests described are primarily engineering and laboratory evaluations, not clinical studies requiring expert ground truth establishment in the traditional sense (e.g., for image interpretation).

    4. Adjudication method (e.g., 2+1, 3+1, none) for the test set:

    This information is not applicable or not provided. The listed tests are objective, quantifiable physical and biological tests, not subjective interpretations requiring adjudication.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    No. This document describes a medical device (introducer access set), not an AI-powered diagnostic or assistive technology. Therefore, an MRMC study assessing human reader improvement with AI assistance is not relevant and was not conducted.

    6. If a standalone (i.e., algorithm only without human-in-the loop performance) was done:

    No. This document describes a physical medical device. The concept of "standalone algorithm only" performance is not applicable.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):

    The "ground truth" for the tests performed is based on established engineering standards (e.g., BS EN ISO 11070:1999, EN ISO 9626:1995), biocompatibility standards (e.g., ISO 10993-1:2009), and internal predetermined acceptance criteria derived from the device's intended use and design specifications. These are objective measures rather than expert consensus, pathology, or outcomes data.

    8. The sample size for the training set:

    This refers to a training set for machine learning or AI models. Since this is a physical medical device and not an AI/ML product, there is no "training set" in this context.

    9. How the ground truth for the training set was established:

    As there is no training set for an AI/ML model, this question is not applicable.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1